FDA
Mometasone Furoate
The FDA lists this product in 25 strengths and forms.
Indications
Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: ■ nasal congestion ■ runny nose ■ sneezing ■ itchy nose
Warnings and precautions
Warnings Only for use in the nose. Do not spray into your eyes or mouth.
Pregnancy and breastfeeding
If pregnant or breast-feeding, ask a health professional before use.
Composition
- Active ingredients
- MOMETASONE FUROATE 0.05MG/SPRAY
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- MOMETASONE FUROATE 0.1% · OintmentANDA076624-001 · Discontinued
- MOMETASONE FUROATE 0.1% · OintmentANDA076481-001 · Prescription
- MOMETASONE FUROATE 0.1% · CreamANDA076679-001 · Prescription
- MOMETASONE FUROATE 0.1% · CreamANDA078541-001 · Discontinued
- MOMETASONE FUROATE 0.1% · LotionANDA076788-001 · Discontinued
- MOMETASONE FUROATE 0.05MG/SPRAY · Spray, meteredANDA211706-001 · Discontinued
- MOMETASONE FUROATE 0.05MG/SPRAY · Spray, meteredANDA217438-001 · Discontinued
- MOMETASONE FUROATE 0.05MG/SPRAY · Spray, meteredANDA217460-001 · Discontinued
- MOMETASONE FUROATE 0.1% · Lotion
At a glance
- Brand name
- Mometasone Furoate
- Route
- Nasal
- Dosage form
- Spray, metered
- Applicant
- Aurobindo Pharma
- Status
- Discontinued
- FDA approval
- 22 Nov 2024
- Application
- ANDA217498-001